Skip to content

Rapid Micro Biosystems RPID Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Operating margin-144.2%+15.4pp-141.1%+36.9pp-148.8%+49.5pp-152.1%+67.6pp-159.6%+82.7pp
Net margin-145.8%+5.4pp-140.3%+26.9pp-145.1%+39.8pp-145.6%+58.6pp-151.2%+73.5pp
Returns
Return on equity-116.7%-64.4pp-86.8%-38.3pp-68.8%-23.2pp-59.2%-16.1pp-52.3%-12.1pp
Return on invested capital-120.6%-54.2pp-93.7%-33.3pp-77.1%-19.3pp-87.3%-27.7pp-66.4%-16.8pp
Efficiency
Asset turnover0.5×+0.2×0.4×+0.2×0.3×+0.1×0.3×+0.1×0.3×+0.1×
Liquidity
Current ratio2.6×-2.0×3.3×-1.3×4.2×-1.3×3.7×-2.2×4.6×-2.3×
Leverage
Debt-to-equity1.2×+1.1×0.7×+0.6×0.5×+0.5×0.1×0.0×0.1×0.0×
Per Share
Book value per share$0.45-69.8%$0.74-57.0%$0.99-49.0%$1.22-43.7%$1.49-39.2%
Valuation
Market capitalization$86.19M-43.5%$128.54M+232%$147.66M+287%$148.15M+424%$114.14M+177%
Price / sales2.5×-2.5×3.8×+2.4×4.8×+3.4×4.9×+3.7×3.9×+2.1×
Price / book4.2×+1.4×3.9×+3.4×3.3×+2.9×2.7×+2.4×1.7×+1.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Rapid Micro Biosystems's ratios come from?
Every ratio is computed from Rapid Micro Biosystems's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.